Although CNS demyelination is a hallmark of MS, genetic studies showing an association with the MHC class II HLA-DRB1*15:01 allele [61,62,63,64] suggest that MS has a critical adaptive immune system component that drives disease. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.